Arbutus Biopharma Corp. (ABUS)
5.20
-0.01
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
5.20
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Price : 5.20 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 5.20 | 5.45 | 5.09 | 5.21 | 18.07M |
| Aug 20, 2026 | 4.92 | 4.96 | 4.74 | 4.77 | 1.274M |
| Aug 19, 2026 | 4.83 | 5.18 | 4.83 | 4.98 | 3.428M |
| Aug 18, 2026 | 4.79 | 4.85 | 4.645 | 4.84 | 1.446M |
| Aug 17, 2026 | 4.66 | 4.795 | 4.630 | 4.71 | 1.388M |
| Aug 14, 2026 | 4.60 | 4.71 | 4.55 | 4.67 | 1.439M |
| Aug 13, 2026 | 4.56 | 4.65 | 4.505 | 4.58 | 1.390M |
| Aug 12, 2026 | 4.59 | 4.635 | 4.42 | 4.59 | 1.399M |
| Aug 11, 2026 | 4.60 | 4.72 | 4.60 | 4.67 | 1.048M |
| Aug 10, 2026 | 4.59 | 4.665 | 4.545 | 4.59 | 969216.0 |
| Aug 07, 2026 | 4.57 | 4.65 | 4.53 | 4.63 | 796105.0 |
| Aug 06, 2026 | 4.57 | 4.64 | 4.45 | 4.54 | 1.266M |
| Aug 05, 2026 | 4.46 | 4.69 | 4.45 | 4.62 | 1.705M |
| Aug 04, 2026 | 4.38 | 4.50 | 4.38 | 4.42 | 958756.0 |
| Aug 03, 2026 | 4.34 | 4.425 | 4.31 | 4.36 | 1.421M |
| Jul 31, 2026 | 4.40 | 4.450 | 4.27 | 4.34 | 1.168M |
| Jul 30, 2026 | 4.30 | 4.42 | 4.26 | 4.41 | 786237.0 |
| Jul 29, 2026 | 4.41 | 4.43 | 4.27 | 4.29 | 2.078M |
| Jul 28, 2026 | 4.50 | 4.50 | 4.375 | 4.41 | 633619.0 |
| Jul 27, 2026 | 4.41 | 4.525 | 4.40 | 4.41 | 977802.0 |
| Jul 24, 2026 | 4.46 | 4.51 | 4.37 | 4.38 | 876895.0 |
| Jul 23, 2026 | 4.28 | 4.48 | 4.25 | 4.47 | 1.475M |
| Jul 22, 2026 | 4.51 | 4.52 | 4.31 | 4.33 | 1.432M |
| Jul 21, 2026 | 4.42 | 4.54 | 4.41 | 4.52 | 2.217M |
| Jul 20, 2026 | 4.55 | 4.609 | 4.375 | 4.41 | 1.818M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 138.82 |
| Insmed, Inc. | 124.03 |
| Pfizer Inc. | 27.98 |
| Gossamer Bio, Inc. | 0.1762 |
| Legend Biotech Corp. | 20.95 |
Price Related Metrics
| PE Ratio | 6.638 |
| PS Ratio | 5.559 |
| Price to Book Value | 3.972 |
| Earnings Yield | 15.07% |
| Market Cap | 1.028B |
| Operating PE Ratio | 6.851 |
| Normalized PE Ratio | 6.687 |